Federal Council appoints two new members to ETH Board

On 6 June the Federal Council appointed Martin Keller and Matthias Leuenberger to the ETH Board. Martin Keller will take office on 1 August, succeeding Christiane Leister, who passed away at the beginning of March. From 1 January 2026 Matthias Leuenberger will succeed Susan Gasser, whose term of office comes to an end in December. Martin Keller has many years of experience in corporate management and development and Matthias Leuenberger in leading positions in the pharmaceutical industry, making them ideal new members of the ETH Board.

After holding various management positions in the Swiss agriculture and food industry, Martin Keller joined the international seed company KWS SAAT AG in Einbeck (Germany), where he was in charge of Corporate Marketing & Business Development. He has worked for the fenaco cooperative since 2010, chairing the executive board and heading the Corporate Development Division since 2012. The 55-year-old will leave fenaco at the end of June. He studied agronomy at ETH Zurich, and obtained his doctorate there in 1998.

Matthias Leuenberger worked at Boston Consulting Group for nine years before joining Novartis in Basel in 2004. He held various management positions there, most recently as country president for Switzerland from 2014 to 2024. The 59-year-old was president of scienceindustries from 2018 to the end of May of this year, and is vice president of economiesuisse. He studied law at the University of Bern, qualified as a lawyer in 1993 and obtained a doctorate in 1995 with a thesis on company law.

The ETH Board is the strategic management and supervisory body of the ETH Domain. It comprises ETH Zurich and EPFL as well as the four research institutes PSI, WSL, Empa and Eawag.

This media release originally appeared on the website of the Federal Government.

Drucken

Contact

GS-EAER Communications

+41 58 462 20 07

E-Mail

Contact

GS-EAER Communications

+41 58 462 20 07

E-Mail